Skip to main content
TELCON RF PHARMACEUTICAL. Inc. logo

TELCON RF PHARMACEUTICAL. Inc. — Investor Relations & Filings

Ticker · 200230 ISIN · KR7200230001 KO Manufacturing
Filings indexed 351 across all filing types
Latest filing 2024-06-17 Share Issue/Capital Cha…
Country KR South Korea
Listing KO 200230

About TELCON RF PHARMACEUTICAL. Inc.

http://www.telcon-rf.com

TELCON RF PHARMACEUTICAL. Inc. operates across two primary business segments: radio frequency (RF) components and pharmaceuticals. The RF division specializes in the development, manufacturing, and global sale of components for wireless communication equipment. Its main products include RF coaxial connectors, cable assemblies, coaxial couplers, and distributors. The pharmaceutical and biotechnology division is engaged in the development and sale of medicinal products.

Recent filings

Filing Released Lang Actions
전환청구권행사
Share Issue/Capital Change Classification · 100% confidence The document is a regulatory filing from a Korean company (Telcon RF Pharmaceutical) regarding the 'Exercise of Conversion Rights' (전환청구권행사) for convertible bonds. This type of filing details the conversion of debt into equity, which directly impacts the company's capital structure and share count. According to the provided definitions, announcements regarding new share issues or capital changes fall under the 'Share Issue/Capital Change' (SHA) category.
2024-06-17 Korean
전환청구권행사
Share Issue/Capital Change Classification · 100% confidence The document is a regulatory filing from a Korean company (Telcon RF Pharmaceutical) regarding the exercise of conversion rights (전환청구권행사) for convertible bonds. This type of filing details changes in capital structure, specifically the issuance of new shares resulting from the conversion of debt into equity. According to the provided definitions, announcements regarding new share issues or capital changes fall under the 'SHA' category.
2024-06-14 Korean
주요사항보고서(자기전환사채매도결정)
Capital/Financing Update Classification · 100% confidence The document is a 'Major Matter Report' (주요사항보고서) filed with the Financial Services Commission (금융위원회) in South Korea. It details a specific corporate action: the decision to sell back convertible bonds (자기전환사채매도결정). This type of filing is a regulatory disclosure regarding capital structure and financial transactions, which falls under the 'Regulatory Filings' category as it is a specific Korean regulatory disclosure form that does not fit into the other specialized categories like M&A or Dividend announcements.
2024-06-13 Korean
타법인주식및출자증권취득결정
Major Shareholding Notification Classification · 100% confidence The document is a regulatory filing from Telcon RF Pharmaceutical regarding the acquisition of shares in another company (Abion Inc.) through the exercise of conversion rights from convertible bonds. This type of disclosure, detailing the acquisition of equity in another entity, falls under M&A activity or strategic investment disclosures, which is categorized as 'TAR' (M&A Activity) in the provided schema.
2024-05-29 Korean
타인에대한채무보증결정
Capital/Financing Update Classification · 95% confidence The document is a formal regulatory announcement regarding a 'Decision on Debt Guarantee for Others' (타인에 대한 채무보증 결정) issued by Telcon RF Pharmaceutical. It details the financial guarantee provided to an affiliate, including the amount, duration, and board approval details. As this is a specific regulatory disclosure regarding corporate financial obligations that does not fit into the other specialized categories like M&A or Earnings, it is classified as a Regulatory Filing (RNS).
2024-05-17 Korean
분기보고서 (2024.03)
Interim / Quarterly Report Classification · 100% confidence The document is a 'Quarterly Report' (분기보고서) for the company 'Telcon RF Pharmaceutical' (텔콘알에프제약) covering the period from January 1, 2024, to March 31, 2024. It contains detailed financial statements, business descriptions, and management analysis, which aligns with the definition of an Interim/Quarterly Report (IR). Q1 2024
2024-05-16 Korean

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.